| Issue 1051: April 16, 2013 TOP STORIES
IAC HANDOUTS
JOURNAL ARTICLES AND NEWSLETTERS
CONFERENCES AND MEETINGS TOP STORIES Newly available! IAC's popular full-size laminated versions of the 2013 U.S. immunization schedules. Order a supply for your healthcare setting today! IAC's laminated versions of the 2013 U.S. child/teen and adult immunization schedules are covered with a tough, washable coating that lets them stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. Each has six pages (i.e., three double-sided pages) and is folded to measure 8.5" by 11".  
PRICING 1-4 copies: $7.50 each 5-19 copies: $5.50 each 20-99 copies: $4.50 each 100-499 copies: $4.00 each 500-999 copies: $3.50 each For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email admininfo@immunize.org You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page. Back to top Immunization Schedules web section offers quick access to child, teen, and adult schedules for 2013 Looking for an easy way to find the 2013 recommended immunization schedules for children, and adolescents, as well as adults? It’s all in one place on immunize.org! Visit the Immunization Schedules web section on immunize.org for one-stop access to all the official schedules. In addition to the CDC schedules, this section offers links to IAC’s laminated versions of the schedules, as well as links to electronic versions of the schedules for PC and smartphones from the Society of Teachers of Family Medicine (STFM) and immunization schedulers from CDC. Related Links Back to top CDC publishes report on 2009 varicella death of an unvaccinated, previously healthy Ohio adolescent CDC published Varicella Death of an Unvaccinated, Previously Healthy Adolescent—Ohio,2009 in the April 12 issue of MMWR (pages 261–263). The first paragraph of the article and two paragraphs from the article's Editorial Note are reprinted below. Varicella usually is a self-limited disease but sometimes can result in severe complications and death. Although infants, adults, and immunocompromised persons are at increased risk for severe disease, before varicella vaccine was introduced in 1995, the majority of hospitalizations and deaths from varicella occurred among healthy persons aged <20 years. Introduction of varicella vaccine has substantially decreased varicella incidence, hospitalizations, and deaths in the United States. This report describes a varicella death in an unvaccinated, previously healthy adolescent aged 15 years. In April 2012, as part of the routine review of vital statistics records, the Ohio Department of Health identified a 2009 death with the International Classification of Diseases, 10th Revision code for varicella as the underlying cause. Because varicella deaths are nationally reportable, the Ohio Department of Health conducted an investigation to validate that the coding was accurate. Investigators learned that, on March 12, 2009, the adolescent girl was admitted to a hospital with a 3-day history of a rash consistent with varicella and a 1-day history of fever and shortness of breath. The patient was started on intravenous acyclovir (on day 4 of illness) and broad-spectrum antibiotics and antifungals, but she died 3 weeks later. The case underscores the importance of varicella vaccination, including catch-up vaccination of older children and adolescents, to prevent varicella and its serious complications. Editorial Note Varicella vaccine is highly effective (>95%) in preventing severe varicella and deaths. Varicella-zoster virus (VZV) infection has the potential, even among healthy persons, to cause severe complications, including secondary bacterial infection and sepsis, pneumonia, encephalitis, cerebellar ataxia, and thrombocytopenia; these complications can occur within a few days of rash onset. The Advisory Committee on Immunization Practices recommends routine administration of the first dose of varicella vaccine at age 12–15 months and the second dose at age 4–6 years. Catch-up vaccination also is recommended. Unvaccinated persons who do not have evidence of immunity to varicella should receive 2 doses of varicella vaccine at appropriate intervals, and those who have received 1 dose previously should receive a second dose. Related Links Back to top IAC HANDOUTS IAC updates "When Do Children and Teens Need Vaccinations?"; eight translations are available IAC recently reviewed and made minor revisions to the parent schedule titled When Do Children and Teens Need Vaccinations? The current version of this schedule is available in Spanish, Arabic, Chinese, French, Korean, Russian, Turkish, and Vietnamese. IAC thanks Mustafa Kozanoglu, MD, for the Turkish translation. IAC offers patient schedules for people of all ages in many languages. Related Link IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely. Back to top IAC updates four staff-education materials on pneumococcal vaccination IAC recently updated the following four staff-education pieces. All now reflect new ACIP guidance on administering pneumococcal conjugate vaccine (PCV13) to people age 6–18 years who have certain risk factors for pneumococcal disease. IAC also added an additional page to "Standing Orders for Administering Pneumococcal Conjugate Vaccine to Children"; it is now a two-page document.
IAC's screening checklists for influenza vaccination contraindications are now available in Spanish Updated in October 2012, the following two checklists for contraindications to influenza vaccination are now available in Spanish.
Related Link
IAC updates two hepatitis B handouts, one for parents of adopted children, another for young adults with chronic hepatitis B infection The authors of the following two articles on hepatitis B virus infection recently reviewed and made minor revisions to the articles, which are posted on the IAC website.
Related Link Back to top FEATURED RESOURCES Download a colorful adolescent immunization brochure from King County, WA The Immunization Program of King County (Seattle), WA, recently posted a brochure titled Is your 11 to 18 year-old protected from serious diseases? Intended for parents, the double-sided brochure presents clear and convincing reasons for vaccinating preteens and teens against meningococcal disease, pertussis, and human papillomavirus. Related Link
Influenza is serious; vaccination is recommended for nearly everyone, so please keep vaccinating your patients Vaccination remains the single most effective means of preventing influenza. Vaccination is recommended for everyone age 6 months and older, so please continue to vaccinate your patients. If you don't provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to the HealthMap Vaccine Finder to locate sites near their workplaces or homes that offer influenza vaccination services. If you are seeking influenza vaccine for your clinic, check the Influenza Vaccine Availability Tracking System (IVATS), which is a resource for healthcare settings looking to purchase influenza vaccine. The IVATS chart contains information from approved, enrolled, and participating wholesale vaccine distributors or manufacturers of U.S. licensed influenza vaccine. Information is updated on an ongoing basis. Following is a list of resources related to influenza disease and vaccination for healthcare professionals and the public.
JOURNAL ARTICLES AND NEWSLETTERS CDC publishes report on human contact with oral rabies vaccine baits in Ohio in 2012 CDC published Human Contacts with Oral Rabies Vaccine Baits Distributed for Wildlife Rabies Management—Ohio, 2012 in the April 12 issue of MMWR (pages 267–269). A press summary of the article is reprinted below. Baits laden with oral rabies vaccines play an important role in the management of rabies in wildlife. Individuals that come across these baits should avoid touching them; and, also not allow their pets to come into contact with the baits. If a sighting or contact occurs, individuals should call the number on the bait or the local health department. . . . A new oral rabies vaccine consisting of recombinant human adenovirus type 5 vector is being field tested in the United States. Another oral rabies vaccine consisting of recombinant vaccinia vector (V-RG) has been used in the United States for more than 20 years. Though rare, there is a risk of human infection from these vaccines. Out of over 138 million V-RG baits that have been dropped, two human infections have occurred. Baiting strategies therefore attempt to minimize human contact. This article reports that there were no adverse events that occurred in humans or pets during an oral rabies vaccine baiting operation in Ohio in 2012. Related Links Back to top CDC publishes report on evaluating surveillance of global polio eradication in 2011–12 CDC published Evaluating Surveillance Indicators Supporting the Global Polio Eradication Initiative, 2011–2012 in the April 12 issue of MMWR (pages 270–274). The first paragraph of the article's Editorial Note is reprinted below. Notable gains in interrupting wild poliovirus (WPV) transmission have occurred since the Global Polio Eradication Initiative (GPEI) was declared a programmatic emergency in January 2012; the number of countries with WPV transmission decreased from 16 in 2011 to five in 2012, and reported WPV cases decreased from 650 to 223, with WPV transmission now primarily in localized "sanctuaries." Acute flaccid paralysis (AFP) surveillance performance indicators met certification-level quality in the majority of countries with poliovirus (PV) circulation during 2011–2012 including polio-endemic countries, and improved during this period in Angola, Central African Republic, and Democratic Republic of Congo; however, critical surveillance gaps remain in parts of Cameroon, Chad, and Niger that border areas of Nigeria with ongoing WPV transmission, and at subnational levels in multiple countries. Back to top CONFERENCES AND MEETINGS New York Academy of Sciences' May 17 symposium on HIV/AIDS will include an update on vaccine trials The New York Academy of Sciences has scheduled a one-day symposium, The Three Zeros of Eliminating HIV/AIDS: Global Science and Policy, for May 17. Among the presentations will be an update on local and international vaccine trials. Back to top  |
About IZ Express
IZ Express is supported in part by Grant No. NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
ISSN 2771-8085
IZ Express Disclaimer
ISSN 2771-8085
Editorial Information
-
Editor-in-ChiefKelly L. Moore, MD, MPH
-
Managing EditorJohn D. Grabenstein, RPh, PhD
-
Associate EditorSharon G. Humiston, MD, MPH
-
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA -
Style and Copy EditorMarian Deegan, JD
-
Web Edition ManagersArkady Shakhnovich
Jermaine Royes -
Contributing WriterLaurel H. Wood, MPA
-
Technical ReviewerKayla Ohlde